Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort-Reference-Cited by-同舟云学术

Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort

Published:2018-06 Issue:6 Volume:5 Page:e252-e260
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Feldman Brian M,Rivard Georges E,Babyn Paul,Wu John K M,Steele MacGregor,Poon Man-Chiu,Card Robert T,Israels Sara J,Laferriere Nicole,Gill Kulwant,Chan Anthony K,Carcao Manuel,Klaassen Robert J,Cloutier Stephanie,Price Victoria E,Dover Saunya,Blanchette Victor S

Publisher

Elsevier BV

Subject

Hematology

Reference41 articles.

1. Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics;Forsyth;Haemophilia,2014

2. Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18–30 years) with hemophilia;Witkop;Am J Hematol,2015

3. Impact of severe haemophilia A on patients' health status: results from the guardian(™) 1 clinical trial of turoctocog alfa (NovoEight(®));Ozelo;Haemophilia,2015

4. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia;Manco-Johnson;N Engl J Med,2007

5. Burden of illness: direct and indirect costs among persons with hemophilia A in the United States;Zhou;J Med Econ,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A long term outcomes analysis of severe haemophilia A boys receiving 4 years prophylaxis on the Chinese Haemophilia Individualized escalating low dose Prophylaxis (CHIPS);Thrombosis Research;2024-09

2. Investigation and Analysis of the Current Status of Health-Related Quality of Life in Adolescents with Hemophilia in Hubei Province;British Journal of Hospital Medicine;2024-08-30

3. Joint health and pain in the changing hemophilia treatment landscape;Expert Review of Hematology;2024-07-15

4. Management of Severe Hemophilia A: Low-Dose Prophylaxis vs. On-Demand Treatment;Cureus;2023-07-05

5. Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A;Research and Practice in Thrombosis and Haemostasis;2023-01